MetaVia MTVA
NASDAQ MTVA
$1.46 +0.02 (+1.39%)
At close: Aug 21, 2026 · 4:00 PM EDT

MetaVia (MTVA) EBITDA (2015 - 2026)

MetaVia's (MTVA) quarterly EBITDA came in at -$2.0 million in Q4 2025, up 63.37% YoY from -$1.3 million in Q4 2024, and up 41.12% on a QoQ basis from -$3.5 million in Q3 2025.

MetaVia (MTVA) EBITDA (2015 - 2026) Analysis & Trends

MetaVia (MTVA) has 11 years of EBITDA data on file, last reported at -$2.0 million in Q4 2025.

  • Quarterly EBITDA rose 63.37% year-over-year to -$2.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$13.7 million (up 52.42% YoY) and the FY2025 annual result came in at -$13.7 million, up 52.42% from the prior year.
  • EBITDA grew to -$2.0 million in Q4 2025, from -$3.5 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $7.2 million in Q4 2023 to a low of -$10.4 million in Q4 2022.
  • A 5-year average of -$3.9 million and a median of -$3.6 million in 2023 frame the typical range for EBITDA.
  • Annual changes were most pronounced in 2023 — EBITDA surged 168.79% — and 2024, when it plunged 1273.84%.
  • Tracing MTVA's EBITDA over 5 years: stood at -$4.6 million in 2021, then plunged by 128.23% to -$10.4 million in 2022, then soared by 168.79% to $7.2 million in 2023, then sank by 177.84% to -$5.6 million in 2024, then surged by 63.37% to -$2.0 million in 2025.
  • The last three EBITDA figures came in at -$2.0 million (Q4 2025), -$3.5 million (Q3 2025), and -$4.3 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 1.29 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 493.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -815.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 325.05 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 231.44 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -375.75 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -1.55 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 133.12 Mn
10 MetaVia 8.72 Mn -3.92 Mn - -5.39 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -5.39 Mn
Dec 31, 2025 -2.05 Mn
Sep 30, 2025 -3.48 Mn
Jun 30, 2025 -4.30 Mn
Mar 31, 2025 -3.89 Mn
Dec 31, 2024 -5.59 Mn
Sep 30, 2024 -6.26 Mn
Jun 30, 2024 -10.08 Mn
Mar 31, 2024 -6.88 Mn
Dec 31, 2023 7.18 Mn
Sep 30, 2023 -3.78 Mn
Jun 30, 2023 -734,000.00
Mar 31, 2023 -2.52 Mn
Dec 31, 2022 -10.43 Mn
Sep 30, 2022 -3.10 Mn
Jun 30, 2022 -3.22 Mn
Mar 31, 2022 -2.87 Mn
Dec 31, 2021 -4.57 Mn
Sep 30, 2021 -3.45 Mn
Jun 30, 2021 -3.91 Mn